You Searched For "innovation in biotech" and got 20 results
Sort By:
Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials
The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…
PTI
Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year
Despite more attention being paid to diversity efforts, 92% of top biopharma CEOs are men, an Insid…
Shelby Livingston,Andrew Dunn
Covaxin supply to government at ₹150 per dose is not sustainable, says Bharat Biotech
The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price …
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
The 9 biotechs that stand to win after the FDA took a new approach to approving Biogen's Alzheimer's drug
These are Insider's biggest healthcare stories for June 9.
Lydia Ramsey Pflanzer
Bharat Biotech inks deal to supply Covaxin to Brazil
Hyderabad, Jan 12 (IANS) Bharat Biotech on Tuesday announced it has signed an agreement with Precis…
Covaxin priced at ₹600 and ₹1200 for state and private hospitals respectively
The company also revealed that Covaxin’s export prices have been set at $15-$20. In a stateme…
PTI
How 4 US cities are building resilience by focusing on clean energy, innovation, and smart infrastructure
Insider highlighted Honolulu, San Antonio, Boston, and Raleigh-Durham as cities striving to be more…
Erica Sweeney
KemPharm skyrockets 90% after FDA approval of ADHD treatment
KemPharm stock skyrocketed on Wednesday after the FDA approved the company's once-daily treatment f…
Will Daniel
Bharat Biotech claims its Covid 19 vaccine Covaxin will work against UK strain
Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant stra…
Bharat Biotech dispatches 1st batch of Covaxin for immunisation drive
New Delhi, Jan 4 (IANS) Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccin…
Covaxin can deal with new Covid strains too: Bharat Biotech
Hyderabad, Dec 30 (IANS) Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will b…
Hyderabad : Vaccine capital of the world
This southern city, already recognised as a global information technology destination, proved …
India's first vaccine candidate - Bharat Biotech's Covaxin begins its Phase-3 trials
Hyderabad, Nov (IANS) Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-…
IIT-Kharagpur shows how to innovate, bags maximum laurels at innovation awards
"After four rounds of evaluation, 19 teams have been selected for innovation awards and 24 for appr…
The election's consequences for digital health
These are the top stories written by Business Insider's healthcare team for the week ending October…
Blake Dodge
Bharat Biotech partners with Washington varsity for intranasal COVID-19 vaccine
The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA,…
Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine
The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine, accor…
Ben Winck
Billionaire investor Chamath Palihapitiya files for 4 new biotech-focused SPACs that seek to raise $800 million
The latest additions build on Palihapitiya's roster of 6 special-purpose acquisition companies alre…
Shalini Nagarajan
UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms
The probability of a patient receiving the drug to require ventilation or die dropped 79% compared …